Circulating tumour DNA in patients with Hodgkin lymphoma

Article Properties
  • Publication Date
    2020/06/02
  • Journal
  • Indian UGC (journal)
  • Refrences
    19
  • Citations
    1
  • Alexandra Kredátusová
  • Veronika Hanáčková
  • Marie Lukášová
  • Helena Urbánková
  • Vít Procházka
Cite
Kredátusová, Alexandra, et al. “Circulating Tumour DNA in Patients With Hodgkin Lymphoma”. Onkologie, vol. 14, no. 3, 2020, pp. 122-5, https://doi.org/10.36290/xon.2020.024.
Kredátusová, A., Hanáčková, V., Lukášová, M., Urbánková, H., & Procházka, V. (2020). Circulating tumour DNA in patients with Hodgkin lymphoma. Onkologie, 14(3), 122-125. https://doi.org/10.36290/xon.2020.024
Kredátusová A, Hanáčková V, Lukášová M, Urbánková H, Procházka V. Circulating tumour DNA in patients with Hodgkin lymphoma. Onkologie. 2020;14(3):122-5.
Refrences
Title Journal Journal Categories Citations Publication Date
Hématologie 2018
10.1200/JCO.2016.66.4482
10.1200/JCO.2017.77.3994
STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line Leukemia
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Medicine (General)
33 2009
Liquid biopsy in lymphoma Haematologica
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Medicine (General)
41 2019
Citations
Title Journal Journal Categories Citations Publication Date
Inflamatorní lymfomy Onkologie 2020